Riikka Oksala

680 total citations
20 papers, 492 citations indexed

About

Riikka Oksala is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Riikka Oksala has authored 20 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Genetics. Recurrent topics in Riikka Oksala's work include Prostate Cancer Treatment and Research (17 papers), Hormonal and reproductive studies (11 papers) and Estrogen and related hormone effects (10 papers). Riikka Oksala is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Hormonal and reproductive studies (11 papers) and Estrogen and related hormone effects (10 papers). Riikka Oksala collaborates with scholars based in Finland, Sweden and France. Riikka Oksala's co-authors include Pekka Kallio, Reetta Riikonen, Gerd Wohlfahrt, Laura Ravanti, Pirjo Nykänen, Olli Törmäkangas, Jorma J. Palvimo, Anu‐Maarit Moilanen, Tero Aittokallio and Anders Ågmo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Riikka Oksala

19 papers receiving 487 citations

Peers

Countries citing papers authored by Riikka Oksala

Since Specialization

Citations

This map shows the geographic impact of Riikka Oksala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riikka Oksala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riikka Oksala more than expected).

Fields of papers citing papers by Riikka Oksala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riikka Oksala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riikka Oksala. The network helps show where Riikka Oksala may publish in the future.

Co-authorship network of co-authors of Riikka Oksala

This figure shows the co-authorship network connecting the top 25 collaborators of Riikka Oksala. A scholar is included among the top collaborators of Riikka Oksala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riikka Oksala. Riikka Oksala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis 2022 ·Molecular Cancer Therapeutics ·(unknown), Reetta Riikonen, (unknown), Päivi Taavitsainen, (unknown), Marcin Chruściel, Stefan Karlsson, Petteri Rummakko, (unknown), Gerd Wohlfahrt, (unknown), Annamari Vuorela, Heikki Joensuu, Tapio Utriainen, Karim Fizazi, Riikka Oksala	15
2	High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice 2022 ·iScience ·(unknown), Petra Sipilä, (unknown), Riikka Oksala, Matias Knuuttila, Arfa Mehmood, (unknown), Teemu D. Laajala, Tero Aittokallio, Asta Laiho, Laura L. Elo, Claes Ohlsson, (unknown), Pekka Kallio, Sari Mäkelä, Mika Mustonen, Matti Poutanen	6
3	SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer 2019 ·Journal of the Endocrine Society ·Riikka Oksala, (unknown), Reetta Riikonen, Kati Räsänen, (unknown), (unknown), Petteri Rummakko, Gerd Wohlfahrt, Mika Mustonen	3
4	ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer 2018 ·European Urology Focus ·Katriina Peltola, Petri Bono, Robert H. Jones, Egils Vjaters, Pirjo Nykänen, Annamari Vuorela, Riikka Oksala, Pasi Pohjanjousi, Mika Mustonen, Karim Fizazi, Christophe Massard	5
5	Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts 2018 ·American Journal Of Pathology ·(unknown), Riikka Oksala, Matias Knuuttila, Arfa Mehmood, (unknown), Teemu D. Laajala, Daniel Nicorici, Tero Aittokallio, Asta Laiho, Laura L. Elo, Claes Ohlsson, Pekka Kallio, Sari Mäkelä, Mika Mustonen, Petra Sipilä, Matti Poutanen	18
6	Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1 2018 ·The Journal of Steroid Biochemistry and Molecular Biology ·Riikka Oksala, (unknown), Reetta Riikonen, Petteri Rummakko, (unknown), (unknown), Gerd Wohlfahrt, Päivi Taavitsainen, (unknown), (unknown), (unknown), (unknown), Pekka Kallio, Mika Mustonen	16
7	CYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer. 2018 ·Journal of Clinical Oncology ·Riikka Oksala, (unknown), (unknown), (unknown), Reetta Riikonen, (unknown), Petteri Rummakko, Gerd Wohlfahrt, Pekka Kallio, Mika Mustonen	4
8	CYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer 2018 ·Annals of Oncology ·Riikka Oksala, Kati Räsänen, (unknown), Reetta Riikonen, (unknown), (unknown), (unknown), Petteri Rummakko, Gerd Wohlfahrt, Mika Mustonen	1
9	ODM-208, a novel CYP11A1-inhibitor as a therapeutic approach for the treatment of castration-resistant prostate cancer 2017 ·Annals of Oncology ·Riikka Oksala, (unknown), (unknown), Reetta Riikonen, (unknown), Petteri Rummakko, Gerd Wohlfahrt, Annamari Vuorela, Mika Mustonen, Pekka Kallio	2
10	Antiandrogens Reduce Intratumoral Androgen Concentrations and Induce Androgen Receptor Expression in Castration-Resistant Prostate Cancer Xenografts 2017 ·American Journal Of Pathology ·Matias Knuuttila, Arfa Mehmood, (unknown), Emrah Yatkin, Merja R. Häkkinen, Riikka Oksala, Teemu D. Laajala, Henrik Ryberg, David J. Handelsman, Tero Aittokallio, Seppo Auriola, Claes Ohlsson, Asta Laiho, Laura L. Elo, Petra Sipilä, Sari Mäkelä, Matti Poutanen	10
11	Contribution of mouse adrenal glands to intratumor androgens and growth of castration-resistant prostate cancer xenografts. 2017 ·Journal of Clinical Oncology ·Elahe A. Mostaghel, (unknown), (unknown), Ailin Zhang, (unknown), Eva Corey, T.M. Penning, Riikka Oksala, Lawrence D. True, Peter S. Nelson	1
12	Abstract 4968: Importance of tumor microenvironment in the preclinical estrogen receptor positive breast cancer- Primary tumor and bone metastasis models 2017 ·Cancer Research ·(unknown), Mari I. Suominen, (unknown), Jenni H. Mäki-Jouppila, Jussi M. Halleen, Riikka Oksala	1
13	Optimized design and analysis of preclinical intervention studies in vivo 2016 ·Scientific Reports ·Teemu D. Laajala, (unknown), (unknown), Vidal Fey, Amanpreet Kaur, Matias Knuuttila, (unknown), Riikka Oksala, Jukka Westermarck, Sari Mäkelä, Matti Poutanen, Tero Aittokallio	28
14	ODM-204, a novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer. 2016 ·Journal of Clinical Oncology ·Pekka Kallio, Riikka Oksala, (unknown), Reetta Riikonen, Petteri Rummakko, (unknown), Mika Mustonen	0
15	Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies 2015 ·Scientific Reports ·Anu‐Maarit Moilanen, Reetta Riikonen, Riikka Oksala, Laura Ravanti, (unknown), Gerd Wohlfahrt, Pirjo Nykänen, Olli Törmäkangas, Jorma J. Palvimo, Pekka Kallio	282
16	ODM-204: A novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer—Preclinical data. 2015 ·Journal of Clinical Oncology ·Riikka Oksala, (unknown), Reetta Riikonen, Petteri Rummakko, (unknown), Pekka Kallio	1
17	Castration Induces Up-Regulation of Intratumoral Androgen Biosynthesis and Androgen Receptor Expression in an Orthotopic VCaP Human Prostate Cancer Xenograft Model 2014 ·American Journal Of Pathology ·Matias Knuuttila, Emrah Yatkin, (unknown), (unknown), Teemu D. Laajala, Tero Aittokallio, Riikka Oksala, Merja R. Häkkinen, Pekka Keski‐Rahkonen, Seppo Auriola, Matti Poutanen, Sari Mäkelä	53
18	432 ODM-203, a novel, selective and balanced FGFR and VEGFR inhibitor with strong anti-tumor activity in FGFR- and VEGFR-dependent cancer models 2014 ·European Journal of Cancer ·Tim H. Holmström, Anu‐Maarit Moilanen, Tero Linnanen, Gerd Wohlfahrt, Stefan Karlsson, Riikka Oksala, Timo Korjamo, Mari Björkman, (unknown), (unknown), (unknown), (unknown), Raghuveer Ramachandra, (unknown), (unknown), Murali Ramachandra, Pauliina Kallio	1
19	ODM-201, a new generation androgen receptor inhibitor for castration-resistant prostate cancer: Preclinical and phase I data. 2013 ·Journal of Clinical Oncology ·Karim Fizazi, Christophe Massard, Nicholas D. James, Stéphane Culine, Robert H. Jones, Riikka Oksala, (unknown), (unknown), Laura Ravanti, Pekka Kallio	19
20	Sexual incentive motivation in male rats requires both androgens and estrogens 2009 ·Hormones and Behavior ·Martti Attila, Riikka Oksala, Anders Ågmo	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact